IPO SnapShot

BANKA BIOLOO LTD.

IPODATE
Feb 05, 2018 TO Feb 14, 2018
LISTINGDATE
2/27/2018 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 10

per share

ISSUESIZE
₹ 12.627 Cr
PRICEBAND
₹ 115

per share

MARKETLOT
1200

shares

OBJECTIVE

The Objects of the Issue is to raise funds to:(a) Finance capital expenditures at existing Inoculum unit at Aler (b) Finance capital expenditures at proposed new unit at Ibrahimpatnam (c) Finance Working Capital Requirements (d) General Corporate Purposes and (e) Issue Related Expenses

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

OVERVIEW Our company was incorporated in 2012 with an aim to provide sanitation infrastructure and hygienic solutions for human waste treatment and disposal. After receiving our certificate of incorporation, we took over the running business of our promoter, ‘Banka Enterprises’, a sole proprietorship through a business takeover agreement dated Feb 1, 2013. For further details please refer t...

ADDRESS

Address: A–109
Express Apartment
Lakdi Ka Pool
City: Hyderabad,
State: Telangana
Pincode: 500004
Phone: 8688825013
Email: info@bankabio.com / cs@bankabio.com
Website: www.bankabio.com

LISTED AT

NSE

LEAD MANAGER

Aryaman Financial Services Ltd.

PROMOTERS

Namita Banka

PROMOTER'S HOLDING

Total Share Capital

2463216

Offered to Public

1098000

Promoter's Holding (Pre-Issue)

81.71

Promoter's Holding (Post-Issue)

59.9
REGISTRAR

Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.